Member Info for 13martyn13

I wouldn’t be surprised if the final divi is kept at the same as the previous three, at 1.75p giving 7p for the year.
Then going forward moving up on a quarterly basis from the 1.75p level.

FNX are a main buy recommendation in the SCSW this weekend, which should help with any rise tomorrow.
Looking forward to the results myself, but as you say it’s the outlook that matters in these markets.

Looks like things are still progressing, nice to get an update this morning.
Don’t think it will be noticed much, especially on a day like this.
Very unsettled world we’re living at the moment, such a waste of life, energy and money.
These leaders who want to takeover their neighbours, could leave such a better legacy by building a prosperous peaceful country for their people to live their one and only life in.
It’s the same all through history though, we just don’t learn.

Should be a better day, particularly for OBD, it can move very fast went there’s buying pressure.
Not sure if that will happen today, but I agree, well done OBD, the launch should stop the share price drift, but more importantly help people who are unfortunate enough to be diagnosed with cancer.

The RNS this morning said the CEO has sold and left.

In addition, Paul Smith has left his role as Chief Executive Officer ("CEO") and stepped down from the board with immediate effect.

Grabs his money first, and then runs for the hills, just shows what type of person he is, leaving colleagues and shareholders to deal with the fallout.

After today you might have to pass me kneecap Ken’s phone number :-)

Yes I was surprised he had left.
£500 per 1/4 is too high then, I was pulling the figure from memory and obviously got it wrong, apologies all.
The revenue of £100,000 split between 2500 is £40 a head, you would expect the costs per patient to increase as the benefits in health are recorded.
Today’s share price tells a different story, but a positive day regarding news.

2500 prescriptions x £500 a quarter is £1.25M, it can easily ramp up, (I think that was the cost per quarter).
£100,000 revenue reported works out at £40 a patient, and I’m sure STX won’t keep it at the introductory price forever , plenty to surprise on the upside this year.
Great value from my perspective and in the finncap note today they expect £10M debt after the cash has gone, no mention of cash raises, and the £12M in hand is £5M better than their forecasts.

Hi dustofnations, from this morning’s finncap note:
Shield has made some organisational changes to its commercial team in the past month, which are expected to benefit the company going forward: - Brian Groch, former President of the US business and Chief Commercial Officer, is no longer with the company. - A new Head of Sales and three regional directors have been taken on as Shield employees, prior to which these roles were filled by IQVIA employees through Shield’s contract sales model. These new hires bring extensive experience along with the obvious benefits from being Shield employees.

Brian Groch, former President of the US business and Chief Commercial Officer, is no longer with the company”
I hadn’t realised they’d parted company.
Going in the the right direction, but I don’t think it’s going to help the share price yet.
2500 prescriptions is good, but sold at nominal costs, obviously we need to get the product out there, but I would expect the income to increase from those 2500 patients after a while, because surely STX aren’t going to keep the patient supplied at cost value forever.
2500 prescriptions x £500 a quarter is £1.25M, it can easily ramp up, (I think that was the cost per quarter, happy to be corrected).
I couldn’t post earlier, site was down for me, but topped up at 27.5p & 29.4p while waiting to post.

Rising nicely into the close, hopefully some news is in the pipeline

Any views on the presentation that just finished?
I only caught the last 10 minutes.

Interesting GraphicBoy, I didn’t know that thank you.
I can’t see a trade for that amount, at that time on Sharepad, do you mean the last one at 17:06pm for 200,000?

237,523 late buy trade before close just shown up at 4.168p, also a 200,000 unknown trade at just after 5pm at 4.1p, possibly a sell.

They’re buys, just showing as unknown because they were delayed being published

The 57,166 sale was probably the same holding that was bought 7 days ago at 3.49p, gave them a £303 profit, not too bad, but expecting a lot bigger gains to come.

Yes I believe that’s how it works.
I always thought we got notified when they sold anything, but had it explained to me late last year that we get informed when they pass a certain % level.

I agree roace, I’m glad they’re not looking after my money.
Hopefully we can make some headway if the selling has stopped.

There’s our seller then, Armistice Capital LLC, sold about 2,870,000 shares